A detailed history of Global X Japan Co., Ltd. transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Global X Japan Co., Ltd. holds 76,173 shares of BMY stock, worth $3.57 Million. This represents 0.31% of its overall portfolio holdings.

Number of Shares
76,173
Previous 16,904 350.62%
Holding current value
$3.57 Million
Previous $762 Million 438.95%
% of portfolio
0.31%
Previous 0.07%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2025

Jan 13, 2026

BUY
$42.6 - $49.08 $2.52 Million - $2.91 Million
59,269 Added 350.62%
76,173 $4.11 Billion
Q3 2025

Oct 15, 2025

BUY
$43.31 - $48.98 $719,119 - $813,263
16,604 Added 5534.67%
16,904 $762 Million
Q2 2025

Jul 11, 2025

BUY
$44.12 - $59.6 $13,236 - $17,880
300 New
300 $13.9 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $99.5B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Global X Japan Co., Ltd. Portfolio

Follow Global X Japan Co., Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Global X Japan Co., Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Global X Japan Co., Ltd. with notifications on news.